Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I J Jacobs

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
BJOG : an International Journal of Obstetrics and Gynaecology|February 25, 2000
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screeningU Menon, A Talaat, A N Rosenthal, et al.
Radiology|August 3, 1999
Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experienceP D Peppercorn, A R Jeyarajah, R Woolas, et al.
British Journal of Cancer|July 17, 1999
Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevationU Menon, A Talaat, A R Jeyarajah, et al.
Gynecologic Oncology|October 1, 1995
Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic massesR P Woolas, M R Conaway, F Xu, et al.
Gynecologic Oncology|January 6, 2000
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutationsR P Zweemer, P J van Diest, R H Verheijen, et al.
Cancer Research|March 15, 1993
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locusI J Jacobs, S A Smith, R W Wiseman, et al.
British Journal of Cancer|June 4, 2009
Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle studyM Widschwendter, H Lichtenberg-Frate, G Hasenbrink, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 1999
Differences between hereditary and sporadic ovarian cancerR P Zweemer, R H Verheijen, F H Menko, et al.
Journal of the National Cancer Institute|September 15, 1993
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancerM F Kohler, J R Marks, R W Wiseman, et al.
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
BJOG : an International Journal of Obstetrics and Gynaecology|February 25, 2000
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screeningU Menon, A Talaat, A N Rosenthal, et al.
Radiology|August 3, 1999
Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experienceP D Peppercorn, A R Jeyarajah, R Woolas, et al.
British Journal of Cancer|July 17, 1999
Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevationU Menon, A Talaat, A R Jeyarajah, et al.
Gynecologic Oncology|October 1, 1995
Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic massesR P Woolas, M R Conaway, F Xu, et al.
Gynecologic Oncology|January 6, 2000
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutationsR P Zweemer, P J van Diest, R H Verheijen, et al.
Cancer Research|March 15, 1993
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locusI J Jacobs, S A Smith, R W Wiseman, et al.
British Journal of Cancer|June 4, 2009
Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle studyM Widschwendter, H Lichtenberg-Frate, G Hasenbrink, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 1999
Differences between hereditary and sporadic ovarian cancerR P Zweemer, R H Verheijen, F H Menko, et al.
Journal of the National Cancer Institute|September 15, 1993
Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancerM F Kohler, J R Marks, R W Wiseman, et al.
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
Pageof 8